Westlake Omics
Hangzhou
About Westlake Omics
Westlake Omics focuses on applying mass spectrometry-based proteomics and other Omics technologies to address pressing clinical needs. It is committed to making breakthroughs in precision medicine and drug R&D with an unwavering focus on critical issues that impact life and health. This vision is driven by AI-empowered high-throughput proteomic analysis of minute amounts of clinical specimens and Omics technologies, supported by technological innovation and multi-modal big data. It was founded in 2020 and is based in Hangzhou, Zhejiang, China.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Funding stage: Seed
- Last round: Seed (Jan 2022)
- Website: westlakeomics.comen
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/westlake-omics-3266649 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.